Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,288 total articles
Marilyn Matz, a director at Teradyne, Inc. (NASDAQ:TER), recently sold 1,200 shares of the company's common stock, resulting in a total transaction value of $427,572. The sale was executed on July 15, 2026, at a price of $356.31 per share, under a Rule 10b5-1 sales plan adopted on February 13, 2026. Following the transaction, Matz directly holds 16…
Stephen F. Page, a director at AeroVironment Inc. (NASDAQ:AVAV), has executed a sale of company shares valued at $35,464. The transaction, conducted through a pre-arranged trading plan, reduces the indirect holdings of the Stephen F. Page Living Trust. The sale occurs against a backdrop of mixed analyst sentiment and recent operational developments…
Horizon Kinetics Asset Management LLC has executed a new purchase of RENN Fund, Inc. shares, according to a recent Form 4 filing submitted to the Securities and Exchange Commission. The transaction underscores the firm's continued financial engagement with the fund, which it advises and holds a significant ownership stake in. The purchase adds to H…
Phreesia, Inc. (NASDAQ: PHR) director Lisa Egbuonu-Davis sold 536 shares of the company's common stock on July 14, 2026, totaling $5,735 at a price of $10.70 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on December 16, 2025. Following the sale, Egbuonu-Davis directly holds 37,780 shares of Phreesia. The stock cur…
UMH Properties director Mitchell William Edward acquired 67.80 shares on July 15, 2026, through the company's Dividend Reinvestment and Stock Purchase Plan. The transaction occurred at $14.75 per share, totaling $1,000, which was priced below the contemporaneous market rate of $15.67. This purchase brings Edward's direct holdings to 34,133.27 share…
Kevin S. Miller, who serves as Executive Vice President, Chief Financial Officer, and Treasurer at UMH Properties, Inc. (NASDAQ: UMH), has executed a share purchase, adding to his direct holdings in the real estate investment trust. This transaction occurs against a backdrop of significant corporate developments, including a recent leadership appoi…
Jan Gommaar M. Vleugels, Chief Operating Officer - International at Alliance Laundry Holdings Inc. (NASDAQ: ALH), sold 75,000 shares of common stock on July 15, 2026. The transaction, valued at $1,905,000, was executed under a Rule 10b5-1 trading plan established on March 16, 2026. The sale occurred as the stock traded near $25.32, reflecting a 24%…
Gregg Williams, a director and significant shareholder in Vivani Medical, Inc. (NASDAQ: VANI), completed a $999,999 purchase of 793,650 shares on July 15, 2026. The transaction, structured as a private sale under an agreement dated August 11, 2025, aligns with the company's recent corporate developments and clinical progress. Williams' acquisition …
Anixa Biosciences Inc. (NASDAQ:ANIX) director Lewis H. Titterton Jr. executed a purchase of 2,797 common shares on July 15, 2026, at $3.28 per share. The acquisition brings his direct holdings to 974,967 shares. The biotech firm continues to advance its clinical pipeline, including a Phase 1 CAR-T therapy for ovarian cancer and a breast cancer vacc…
Richard Chen, serving as both President and Chief Medical Officer at Personalis, Inc. (NASDAQ: PSNL), executed a significant divestment of company equity on July 15, 2026. The transaction involved the sale of 100,000 shares, generating proceeds of $1,515,000. This activity was facilitated by a Rule 10b5-1 trading plan adopted in late December 2025,…
Alclear Investments, LLC, a key shareholder and director of Clear Secure, Inc. (NASDAQ: YOU), executed a significant sale of Class A common stock totaling approximately $5.38 million on July 13, 2026. The transaction, conducted under a pre-existing Rule 10b5-1 trading plan, involved the liquidation of 100,757 shares at prices ranging from $53.00 to…
Clear Secure Inc. (NASDAQ: YOU) Chief Executive Officer Caryn Seidman Becker completed a significant divestment of 100,757 Class A common shares, realizing approximately $5.38 million in proceeds. The transaction, executed on July 13, 2026, was part of a Rule 10b5-1 trading plan established in March 2026. This sale follows a period of robust stock …
Thrivent Financial for Lutherans, a notable shareholder in Gloo Holdings, Inc. (GLOO), executed a series of sales involving 190,000 shares of Class A Common Stock between July 13 and July 15, 2026. The divestment, totaling $634,838 in aggregate value, occurred while the stock traded around $3.36, marking a significant 58% decline over the previous …
Sheena Jonathan, co-founder and director at Natera Inc., liquidated $836,898 worth of Natera common stock on July 13, 2026. The transaction involved the sale of 3,150 shares priced between $262.716 and $268.387 per share. This activity was executed under a Rule 10b5-1 plan established on December 12, 2025. Following the sale, Jonathan retains direc…
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Chief Medical Officer Rodman David Malcom executed two separate sales of company common stock totaling $556,671 on July 13 and July 15, 2026. The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan established on October 6, 2025. Concurrently with the initial sale on July 13, Mr. Malc…
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) CEO Jon Congleton executed a sale of 10,700 shares of the company's common stock on July 13, 2026, totaling $291,441. The transaction, conducted through a Rule 10b5-1 trading plan adopted in January 2025, saw shares sold at prices between $26.80 and $27.58. This sale reduces Congleton's direct holdings but…
CrowdStrike CEO George Kurtz sold 20,000 shares in mid-July 2026, following a 10b5-1 plan adopted in January. The sale occurs as the stock approaches its 52-week high of $217.50, with recent analyst upgrades and a new Chief Product Officer appointment highlighting ongoing strategic developments within the cybersecurity firm.
Denis O'Leary, a director at CrowdStrike Holdings, Inc. (NASDAQ: CRWD), executed a transaction involving the sale of 14,500 shares of the company's Class A common stock, resulting in proceeds of approximately $2.72 million. The sale, facilitated through a charitable remainder trust on July 13, 2026, occurred at prices between $187.72 and $188.12 pe…
CoreWeave, Inc. (NASDAQ:CRWV) Chief Development Officer McBee Brannin executed a significant divestment of company equity on July 13, 2026, selling 53,000 Class A Common Stock shares. The transaction, valued at approximately $4.49 million, was facilitated through a pre-arranged Rule 10b5-1 trading plan established in March 2026. This sale occurred …
Javier Olivan, Chief Operating Officer of Meta Platforms, Inc., executed a series of stock sales totaling $1,429,787 on July 13, 2026. The transactions involved the disposal of Class A Common Stock through both direct holdings and various indirect entities managed by Mr. Olivan and his spouse. All sales were conducted under a Rule 10b5-1 trading pl…
CoreWeave, Inc. (NASDAQ: CRWV) Chief Financial Officer Nitin Agrawal executed a significant sale of company equity on July 13, 2026, divesting $5,512,785 worth of Class A Common Stock. The transactions were facilitated through a Rule 10b5-1 trading plan, a mechanism designed to allow executives to buy or sell shares at predetermined times regardles…
Qualys, Inc. (NASDAQ:QLYS) CEO and President Sumedh S. Thakar executed a sale of 3,200 shares on July 14, 2026, generating approximately $513,610. The transaction was conducted under a Rule 10b5-1 trading plan established in February 2026. Following the sale, Thakar retains direct ownership of 193,486 shares. The executive move coincides with a per…
Intuitive Machines, Inc. (NASDAQ:LUNR) director Kamal Ghaffarian, who holds a significant 10% stake in the firm, executed a substantial divestment of his holdings on July 13, 2026. The transaction involved the sale of 110,976 Class A Common Stock shares, generating approximately $1.74 million in proceeds. This divestment occurred against a backdrop…
Kevin Tang, a major shareholder in Fulcrum Therapeutics, Inc. (NASDAQ: FULC), has executed a series of substantial purchases of the company's common stock. The acquisitions, totaling approximately $891,067, were conducted through Tang Capital Management LLC and its affiliated entities between July 13 and July 15, 2026. This insider buying activity …
Oruka Therapeutics Inc. (NASDAQ: ORKA) Chief Medical Officer Joana Goncalves executed a series of share sales totaling approximately $603,937 on July 15, 2026. The transactions were conducted under a pre-established Rule 10b5-1 trading plan initiated in September 2025. These sales followed the exercise of derivative securities, including employee s…
